R2 Technology strengthened its relationship with GE last month with the signing of an $11 million financing agreement led by GE's financing arm, GE Capital. The financing will be used for working capital purposes as R2 prepares for an initial public
R2 Technology strengthened its relationship with GE last month with the signing of an $11 million financing agreement led by GE's financing arm, GE Capital. The financing will be used for working capital purposes as R2 prepares for an initial public offering that the company plans to launch some time this year. R2 did not disclose what percentage of the Los Altos, CA, company GE Capital now owns.
R2 has developed ImageChecker M1000, a computer-aided diagnosis product for flagging suspicious areas on mammograms. The product is awaiting Food and Drug Administration approval. R2 signed an agreement with GE Medical Systems in April that gives the Milwaukee company rights to the product when sold with full-field digital mammography systems (SCAN 4/29/98). The financing deal with GE Capital was not directly related to the GEMS agreement, according to an R2 spokesperson.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.